Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: November 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01